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To the editor: Several outcomes are suitable to describe and monitor the progression of 1 
disease severity in cognitive disorders and several instruments are available. Often the 2 
choice of such instruments is determined by research questions and available data. There 3 
are specific instruments to measure cognition (global scales such as MMSE (1) or more 4 
extensive neuropsychological assessment batteries), functional abilities (e.g. Katz ADL (2)),  5 
behavior (e.g. NeuroPsychiatric Inventory (3)) and quality of life (e.g. QoLAD (4)). However, 6 
each instrument measures just one aspect while all of them are relevant to a person with 7 
cognitive impairment. Therefore, instruments combining all of these aspects such as the 8 
Clinical Dementia Rating (CDR) scale (5) and the Global Deterioration Scale (6) are usually 9 
based on clinical judgment. In spite of the validity of these composite measures, the need for 10 
clinical expertise to judge each single subject can limit their use in the setting of large 11 
population based studies due to time and financial constraints. In addition, some 12 
instruments have only a limited scale range (e.g. Global Deterioration Scale has 7 stages), 13 
which makes them less suitable to track small changes over time. Therefore, in the 14 
Kungsholmen Project (KP) (7) – a longitudinal, population-based study on aging and 15 
dementia that followed 1810 persons aged 75 and over for up to 12 years, we developed an 16 
alternative composite score combining the MMSE and Katz ADL scores and validated this 17 
score against the CDR scale.  18 
The Composite Cognitive and ADL Functioning Score was calculated by averaging the z-19 
scores of the MMSE and the Katz ADL such that a lower score indicated worse functioning. 20 
For the MMSE the usual instrument and scoring (range 0-30) was used. With respect to Katz 21 
ADL, in KP each of the six Katz ADL items was measured on a three point scale, where  “no”, 22 
“some”, “much help needed” were assigned 0,1 and 2 respectively. This resulted in the score 23 
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range of 0 (no help at all needed) to 12 (much help needed for all of the ADL items). Z-scores 24 
were calculated using the means and standard deviations of participants who were not 25 
demented at the first follow up (FU) and remained without dementia in the second and third 26 
FU (n=573). The resulting composite score was validated against the CDR score, by 27 
calculating the correlation between the composite score and CDR of the samples of the first 28 
(n[total]=1099, n[demented]=235) and second (n[total]=683, n[demented]=190) FU, and by 29 
calculating the correlation of the changes in both scores between the first and the second 30 
follow up. Non-demented participants were assigned a CDR score of zero.  31 
The Pearson correlation coefficient between the composite score and CDR was 0.88 at the 32 
first FU, 0.83 at the second FU, and was 0.62 for the changes in the scores between the first 33 
and second FU. All correlation coefficients were significant at p<0.0001. The composite score 34 
interquartile range was [-0.66 – 0.32] for participants assigned CDR=0, [-2.58 – -0.90] for 35 
CDR=1, [-5.50 – -2.56] for CDR=2, and [-9.61 – -5.23] for CDR=3. 36 
The results indicated high correlations between the Composite Cognitive and ADL 37 
Functioning Score and the CDR score at one point in time. Also changes over time in the 38 
composite score correlated highly with the change in CDR. These observations support the 39 
validity of the composite score that was developed. The fact that the interquartile ranges of 40 
the composite scores per CDR score overlapped little, shows that the composite score could 41 
accurately separate CDR categories. This supports the clinical relevance and provides 42 
information for the clinical interpretation of the Composite Cognitive and ADL Functioning 43 
Score. We conclude that based on the validation by CDR scores in our study population, the 44 
Composite Cognitive and ADL Functioning Score is easy to use and interpret,  clinically relevant, and 45 
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as it reduces the need for clinical judgment of each individual required in comparable composite 46 
measures, it is highly useful for large population-based studies.  47 
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